Cipla, Wockhardt And Pfizer Among Top Winners At DigiPharmaX 2016

The awards recognise the excellence in Digital in the Pharma industry and is the country's first award of this kind

Pfizer Approaches Medivation About Potential Takeover

Pfizer's approach comes less than a week after Sanofi went public with its $52.50 per share cash offer, complaining that Medivation refused to engage.

Investors Stick With Pfizer CEO After Allergan Deal Collapse

In 2014, Pfizer failed in its unsolicited $118 billion bid to buy London-based drugmaker AstraZeneca Plc after that deal ran into staunch opposition from British politicians

Atul: Formulating Success

Atul is an integrated chemical company with about 5,700 customers belonging to 31 industries across the world.

Pfizer, Allergan Scrap $160 Billion Deal After US Tax Rule Change

US drugmaker Pfizer Inc and Ireland-based Allergan Plc walked away from their $160 billion merger on Wednesday, a major win for President Barack Obama, who has been pushing to curb deals in which companies move overseas to save on taxes

Obama's Inversion Curbs Kill Pfizer's $160 Billion Allergan Deal

Pfizer will have to pay Allergan up to $400 million for its expenses as a result of terminating the deal, according to their merger agreement

Vicks Action 500 Extra, Phensedyl Sales To Resume

Many companies have approached the court challenging a decision by the Health Ministry to ban over 340 fixed dose combination drugs

Pfizer Stops Selling Popular Corex Cough Syrup In India After Ban

US pharmaceutical giant Pfizer Inc's India unit said on Monday it had stopped selling its popular Corex cough syrup, after regulators banned it saying it was likely to pose a risk to humans

India Bans More Than 300 Combination Drugs Sold Illegally

In 2014, India set up a committee to review more than 6,000 combinations that had entered the market based only on state regulators' approval

Medecins Sans Frontieres Files To Block Pfizer Patent On Pneumonia Vaccine In India

If government granted Pfizer a patent on its Prevnar 13 pneumonia vaccine, Indian firms would not be able to produce affordable versions of it for domestic use or exports

Pfizer, IIT Delhi Launch Innovation & IP Program

The objective of 'The Pfizer IIT-Delhi Innovation and IP Program' is to nurture, support, celebrate and reward healthcare innovations that are made in India.

Pfizer Set To Buy Allergan For $150 Billion To Create World's Biggest Drug Maker

The deal is sure to draw political ire in a US presidential election year because Pfizer would redomicile to Ireland, where Allergan is registered, in a so-called 'inversion' that would slash its corporate tax rate

Regulators Battle Big Pharma Over Cough Syrup Abuse, Reducing Supplies

Pacific Trade Pact Faces Opposition In US Congress

Pfizer Sells Its Thane Plant To Vidhi Research